1591 related articles for article (PubMed ID: 16336294)
1. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.
Saito M; Nakayama D; Takada M; Hirooka K; Yasumura Y
J Clin Pharm Ther; 2006 Dec; 31(6):535-40. PubMed ID: 17176359
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
4. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
5. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
Vizir VA; Berezin AE
Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
[TBL] [Abstract][Full Text] [Related]
6. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
[TBL] [Abstract][Full Text] [Related]
7. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
[TBL] [Abstract][Full Text] [Related]
8. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients.
Phakdeekitcharoen B; Leelasa-nguan P
Am J Kidney Dis; 2004 Oct; 44(4):738-46. PubMed ID: 15384026
[TBL] [Abstract][Full Text] [Related]
9. Potassium handling with dual renin-angiotensin system inhibition in diabetic nephropathy.
Van Buren PN; Adams-Huet B; Nguyen M; Molina C; Toto RD
Clin J Am Soc Nephrol; 2014 Feb; 9(2):295-301. PubMed ID: 24408116
[TBL] [Abstract][Full Text] [Related]
10. Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
Mooser V; Waeber G; Bidiville J; Waeber B; Nussberger J; Brunner HR
J Clin Hypertens; 1987 Dec; 3(4):510-3. PubMed ID: 2839627
[TBL] [Abstract][Full Text] [Related]
11. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
[TBL] [Abstract][Full Text] [Related]
12. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
Am J Cardiol; 1996 Oct; 78(8):902-7. PubMed ID: 8888663
[TBL] [Abstract][Full Text] [Related]
14. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
Han SW; Won YW; Yi JH; Kim HJ
Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
[TBL] [Abstract][Full Text] [Related]
15. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
16. Clinical factors affecting serum potassium concentration in cardio-renal decompensation syndrome.
Ueno H; Yoshimura M; Nakayama M; Yamamuro M; Nishijima T; Kusuhara K; Nagayoshi Y; Kojima S; Kaikita K; Sumida H; Sugiyama S; Ogawa H
Int J Cardiol; 2010 Jan; 138(2):174-81. PubMed ID: 18804879
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
Weir RA; McMurray JJ; Puu M; Solomon SD; Olofsson B; Granger CB; Yusuf S; Michelson EL; Swedberg K; Pfeffer MA;
Eur J Heart Fail; 2008 Feb; 10(2):157-63. PubMed ID: 18242128
[TBL] [Abstract][Full Text] [Related]
18. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
Shah KB; Rao K; Sawyer R; Gottlieb SS
J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
[TBL] [Abstract][Full Text] [Related]
19. Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic.
Goland S; Naugolny V; Korbut Z; Rozen I; Caspi A; Malnick S
Eur J Intern Med; 2011 Aug; 22(4):424-7. PubMed ID: 21767763
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
Tamirisa KP; Aaronson KD; Koelling TM
Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
